Curis, Inc. (CRIS) vs Propanc Biopharma Inc (PPCB)

Curis, Inc. and Propanc Biopharma Inc are both Biotechnology companies. Propanc Biopharma Inc is the larger, with a market value of $2.1M against $1.8M — 1.2× the size. Curis, Inc. has negative trailing earnings, so its P/E is not meaningful; Propanc Biopharma Inc trades at 0.0×. Across the 10 metrics below, Propanc Biopharma Inc leads on 6 and Curis, Inc. on 4.

Valuation

Metric CRIS PPCB Biotechnology median
P/E n/m 0.00 7.88
P/S 0.19 n/m 11.47
P/B 0.38 0.06 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 4.67 n/m 10.73
Earnings yield (1,713.25%) 257,474.29% (28.84%)
Free cash flow yield (1,748.82%) (739.21%) (23.03%)

Profitability

Metric CRIS PPCB Biotechnology median
Gross margin 99.52% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 455.35% (138.20%) (57.72%)
Return on assets (87.76%) (104.68%) (49.22%)
Return on invested capital 0.00% (116.59%) 0.00%

Growth

Metric CRIS PPCB Biotechnology median
Revenue growth (TTM) (13.43%) — 5.64%
EPS growth (last fiscal year) 91.57% 98.81% —
Revenue growth, 5-year CAGR (2.71%) — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CRIS PPCB Biotechnology median
Debt to equity 0.00 0.05 0.00
Current ratio 0.49 2.37 4.73
Net debt to EBITDA 0.91 (0.01) 0.96

Dividend

Metric CRIS PPCB Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric CRIS PPCB Biotechnology median
Market cap 1.84m 2.14m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack